InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (12 ops.)
Insider track record
CFODisclosed buys
1
Disclosed sells
12
T+90 hit rate
33%
T+90 mean return
-12.1%
Across 15 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Cordova Ashley, Chief Financial Officer. Director active across 1 company, notably NovoCure Ltd. Cumulatively, 32 disclosures have been logged. Breakdown: 1 buy · 12 sells. Total volume traded: €2m. History available since 6 July 2021. The latest transaction was filed on 4 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations32 total
17,638 shares@ US$13.30Ordinary SharesSEC:0001822014-26-000003:0
11,541 shares@ US$13.75Ordinary SharesSEC:0001822014-26-000002:0
81,550 shares@ US$12.223912.3% of flowOrdinary SharesSEC:0001562180-25-006130:0
Ideal exit: 2 Jun 2026 (T+270)
833 shares@ US$15.130.2% of flowOrdinary SharesSEC:0001562180-25-005186:0
151,181 shares@ US$18.1941.2% of flowOrdinary SharesSEC:0001562180-25-002156:0
2,053 shares@ US$18.53630.6% of flowOrdinary SharesSEC:0001562180-25-001975:0
9,345 shares@ US$19.92192.8% of flowOrdinary SharesSEC:0001562180-25-001916:0
9,345 shares@ US$19.92192.8% of flowOrdinary SharesSEC:0001562180-25-001833:0
373 shares@ US$14.7480.1% of flowOrdinary SharesSEC:0001562180-25-000066:0
1,286 shares@ US$12.240.2% of flowOrdinary SharesSEC:0001562180-24-006040:0
688 shares@ US$20.14160.2% of flowOrdinary SharesSEC:0001562180-24-005984:0
102,249 shares@ US$16.3024.1% of flowOrdinary SharesSEC:0001562180-24-001989:0
7,561 shares@ US$11.461.3% of flowOrdinary SharesSEC:0001562180-23-007502:0
883 shares@ US$21.81720.3% of flowOrdinary SharesSEC:0001562180-23-006686:0
1,144 shares@ US$30.25110.5% of flowOrdinary SharesSEC:0001562180-23-006182:0
367 shares@ US$35.280.2% of flowOrdinary SharesSEC:0001562180-23-005757:0
4,730 shares@ US$76.15945.3% of flowOrdinary SharesSEC:0001562180-23-002578:0
1,055 shares@ US$75.27791.2% of flowOrdinary SharesSEC:0001562180-23-002490:0
23,818 shares0Ordinary SharesSEC:0001645113-23-000027:0
66 shares@ US$62.3050.1% of flowOrdinary SharesSEC:0001645113-23-000014:0
2,000 shares@ US$7.150.2% of flowOrdinary SharesSEC:0001645113-22-000096:0
885 shares@ US$79.0371.1% of flowOrdinary SharesSEC:0001645113-22-000077:0
7,122 shares@ US$70.207.7% of flowOrdinary SharesSEC:0001645113-22-000072:0
251 shares@ US$59.0750.2% of flowOrdinary SharesSEC:0001645113-22-000064:0
3,840 shares@ US$15.600.0037% mcap8.6% of flowOrdinary SharesSEC:0001645113-22-000032:0
25 of 32 declarations
About Cordova Ashley
Ashley Cordova serves as the Chief Financial Officer at NovoCure Ltd. She oversees the company's financial management, including budgeting and risk management. Cordova brings expertise in finance and accounting, contributing to strategic decisions that promote NovoCure's growth and sustainability. Her commitment to financial transparency enhances trust among investors and stakeholders.
